Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study

Autores da FMUP
Participantes de fora da FMUP
- Bousquet, J
- Shamji, MH
- Anto, JM
- Klimek, L
- Canonica, GW
- Czarlewski, W
- Devillier, P
- Haahtela, T
- Laune, D
- Mullol, J
- Brussino, L
- Cecchi, L
- Kvedariene, V
- Morais Almeida, M
- Mösges, R
- Niedoszytko, M
- Papadopoulos, NG
- Patella, V
- Pham Thi, N
- Samolinski, B
- Taborda Barata, L
- Toppila Salmi, S
- Sastre, J
- Valiulis, A
- Ventura, MT
- Jutel, M
- Kuna, P
- Valovirta, E
- Zuberbier, T
- Pfaar, O
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 0954-7894, 1365-2222
- Tipo:
- Letter
- Páginas:
- 854-861
- DOI:
- 10.1111/cea.14318
- Link para outro recurso:
- www.scopus.com
Clinical and Experimental Allergy Wiley-Blackwell Publishing Ltd
Citações Recebidas na Scopus: 4
Documentos
- Não há documentos
Filiações
Keywords
- Allergens; Desensitization, Immunologic; Humans; Hypersensitivity; Immunotherapy; Sublingual Immunotherapy; allergen; adaptive immunity; allergic rhinitis; desensitization; grass pollen; human; Letter; sublingual immunotherapy; hypersensitivity; immunotherapy
Campos de estudo
Proyectos asociados
Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021
Effect of a Mobile App on Improving Asthma Control in Adolescents and Adults With Persistent Asthma: A Pilot Randomized Multicentre, Superiority Clinical Trial (mINSPIRERS) - NCT05129527
Investigador Principal: João de Almeida Lopes da Fonseca
Ensaio Clínico Académico (mINSPIRERS) . 2021
Utilização em estudos observacionais do Registo de Asma Grave Portugal.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Observacional Académico (RAG) . 2020
Clinical Research Collaboration Severe Heterogenous Asthma Research collaboration, Patient-centered (CRC SHARP).
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (SHARP) . European Respiratory Society . 2021
Multidimensional phenotyping of severe asthma patients and its impact on disease control and therapeutic response - analysis from the Portuguese Severe Asthma Registry.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (RAG-SPP-GSK) . SPPneumologia . 2022
BREATHE - An oBservational, pRimary data study to characterize severe AsThma pHenotypes and assEss disease burden across the EUCAN region.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (RAG-AZ-BREATHE) . AstraZeneca . 2022
Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers
Investigador Principal: Bernardo Manuel De Sousa Pinto
Estudo Clínico Académico (SARS-CoV-2) . 2021
Efficiency in Spine Care ? Assessing outcomes and costs to inform healthcare improvement
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2022
Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Citar a publicação
Bousquet J,Sousa B,Shamji MH,Anto JM,Klimek L,Canonica GW,Czarlewski W,Devillier P,Haahtela T,Laune D,Mullol J,Brussino L,Cecchi L,Kvedariene V,Morais M,Mösges R,Niedoszytko M,Papadopoulos NG,Patella V,Pham N,Samolinski B,Taborda L,Toppila S,Sastre J,Valiulis A,Ventura MT,Jutel M,Kuna P,Valovirta E,Zuberbier T,Fonseca JA,Pfaar O. Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study. Clin. Exp. Allergy. 2023. 53(8):p. 854-861. IF:6,100. (1).